Why the study?
Does pyridostigmine improve peripheral vascular endothelial dysfunction in rats with myocardial infarction?
Population
Adult Sprague-Dawley rats with myocardial infarction induced by coronary artery ligation
Comparison
Pyridostigmine approximately 31 mg/kg per day… vs Saline intragastrically for 2 weeks
Design
Preclinical
Follow-up
2 weeks
Authors
Loading...
Pyridostigmine may attenuate post-MI endothelial dysfunction in rats; hypothesis-generating and requires clinical trials before any therapeutic consideration.
Does pyridostigmine improve peripheral vascular endothelial dysfunction in rats with myocardial infarction?
In a rat model of myocardial infarction, pyridostigmine attenuates peripheral endothelial dysfunction and maintains endothelial ultrastructural integrity by inhibiting reactive oxygen species production and enhancing NO bioavailability.
Qin et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: